Evidence map›Paper›PMID 23705013›Full record

ArticlePloS one2013

Non-cytotoxic nanomaterials enhance antimicrobial activities of cefmetazole against multidrug-resistant Neisseria gonorrhoeae.

Lan-Hui Li, Muh-Yong Yen, Chao-Chi Ho, Ping Wu, Chien-Chun Wang, Pawan Kumar Maurya, Pai-Shan Chen, Wei Chen, Wan-Yu Hsieh, Huei-Wen Chen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review of Antimicrobial Properties of Titanium Dioxide Nanoparticles.International journal of molecular sciences · 2024
    Review
  3. Review
  4. Review
  5. Article
  6. Nanobiosystems for Antimicrobial Drug-Resistant Infections.Nanomaterials (Basel, Switzerland) · 2021
    Review
  7. Sexually TransmittedMedicines (Basel, Switzerland) · 2021
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Gonorrhea - an evolving disease of the new millennium.Microbial cell (Graz, Austria) · 2016
    Review
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Lan-Hui LiGraduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Muh-Yong Yen
Chao-Chi Ho
Ping Wu
Chien-Chun Wang
Pawan Kumar Maurya
Pai-Shan Chen
Wei Chen
Wan-Yu Hsieh
Huei-Wen Chen
National Taiwan University · TWTaipei City Hospital · TWNational Taiwan University Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence and spread of antibiotic-resistant Neisseria gonorrhoeae has led to difficulties in treating patients, and novel strategies to prevent and treat this infection are urgently needed. Here, we examined 21 different nanomaterials for their potential activity against N. gonorrhoeae (ATCC 49226). Silver nanoparticles (Ag NPs, 120 nm) showed the greatest potency for reducing N. gonorrhoeae colony formation (MIC: 12.5 µg/ml) and possessed the dominant influence on the antibacterial activity with their properties of the nanoparticles within a concentration range that did not induce cytotoxicity in human fibroblasts or epithelial cells. Electron microscopy revealed that the Ag NPs significantly reduced bacterial cell membrane integrity. Furthermore, the use of clinical isolates of multidrug-resistant N. gonorrhoeae showed that combined treatment with 120 nm Ag NPs and cefmetazole produced additive effects. This is the first report to screen the effectiveness of nanomaterials against N. gonorrhoeae, and our results indicate that 120 nm Ag NPs deliver low levels of toxicity to human epithelial cells and could be used as an adjuvant with antibiotic therapy, either for topical use or as a coating for biomaterials, to prevent or treat multidrug-resistant N. gonorrhoeae.

Indexed as

Anti-Infective AgentsCefmetazoleCell DeathCell LineDrug CarriersDrug Resistance, Multiple, BacterialEpithelial CellsFibroblastsHumansIonsMetal NanoparticlesMicrobial Sensitivity TestsModels, BiologicalNanostructuresNeisseria gonorrhoeaeParticle SizeAnti-Infective AgentsCefmetazoleDrug CarriersIonsSilver

Identifiers

PMID23705013
PMCPMC3660602
OpenAlexW2101000006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.